Arcadia Medicine’s CEO Nikita Obidin spoke about our recent milestones and the key initiatives we plan to pursue in the near term.
Arcadia Medicine Announces FDA Clearance of IND Application for a Patented Form of MDMA
We are excited to announce that the FDA has cleared Arcadia’s IND application for AM-1002. Arcadia has raised $9.25M to date with backing from Sam Altman, Fred Ehrsam and Dylan Field.